PubMed期刊
期刊
会议
图书
作者:Niu Tianshui , Shi Qingyi
来源:[J].BMC infectious diseases(IF 3.025), 2019, Vol.19 (1), pp.937PubMed
摘要:BACKGROUND(#br)Infective endocarditis (IE) especially in the elderly is a serious disease, with a worse prognosis.(#br)METHODS(#br)A retrospective cohort study was conducted. A total of 405 patients with definite IE were divided into three groups: 205 patients under 50 years old,...
作者:Niu Tianshui , Zhou Kai ...
来源:[J].Infection and drug resistance, 2018, Vol.11, pp.577-585PubMed
摘要:Colistin is still a "last-resort" antibiotic used to manage human infections due to multidrug-resistant (MDR) Klebsiella pneumoniae . However, colistin-resistant K. pneumoniae (CR-Kp) isolates emerged a decade ago and had a worldwide distribution. The purpose of this study w...
作者:Niu Tianshui , Huang Chen
来源:[J].Infection and drug resistance, 2018, Vol.11, pp.595-606PubMed
摘要:Carbapenem-nonsusceptible Klebsiella pneumoniae (CnSKP) is rapidly emerging as a life-threatening nosocomial infection. The efficacy of tigecycline in the treatment of bloodstream infections (BSIs) remains controversial.;;Data from a total of 428 patients with carbapenem-suscepti...
作者:Niu Tianshui , Wang Yuan ...
来源:[J].Infection and drug resistance, 2019, Vol.12, pp.1665-1674PubMed
摘要:Objectives: Although resistance to colistin is increasingly reported from clinical settings, the genetic mechanisms that lead to colistin resistance in Escherichia coli have not been fully characterized. Here, we assess the evolution of colistin resistance in clinical isolates of...
作者:Niu Tianshui , Xiao Tingting ...
来源:[J].Infection and drug resistance, 2018, Vol.11, pp.103-112PubMed
摘要:The aim of this study was to evaluate the bactericidal effects of moxalactam (MOX), cefotaxime (CTX), and cefoperazone/sulbactam (CFZ/SBT) against extended-spectrum β-lactamase (ESBL) producing Escherichia coli and Klebsiella pneumoniae , using an in vitro pharmacokinetics (...
作者:Niu Tianshui , Xiao TingTing ...
来源:[J].Infection and drug resistance, 2018, Vol.11, pp.2021-2030PubMed
摘要:Background(#br)Carbapenem-resistant Acinetobacter baumannii (CRAB) is a rapidly emerging, life-threatening nosocomial infection. This study aimed to explore the risk factors, clinical features, antimicrobial therapy, and outcomes of CRAB bloodstream infections (BSIs).(#br)Methods...
作者:Niu Tianshui , Luo Qixia ...
来源:[J].Antimicrobial resistance and infection control, 2019, Vol.8, pp.52PubMed
摘要:Background(#br)We retrospectively analyzed the effect of tigecycline and cefoperazone/sulbactam therapies on the prognosis of patients with carbapenem-resistant Acinetobacter baumannii bloodstream infection (CRAB-BSI).(#br)Methods(#br)CRAB-BSI patients receiving tigecycline thera...
作者:Niu Tianshui , Guo Lihua ...
来源:[J].Virulence, 2020, Vol.11 (1), pp.1-13PubMed
摘要:To investigate the virulence of capsular polysaccharide export protein (Wza) in carbapenem-resistant Acinetobacter baumannii and its effect on capsule formation. wza gene knockout and complementation strains were constructed, and changes in bacterial virulence were observed using...
作者:Niu Tianshui , Xiao Tingting ...
来源:[J].Frontiers in cellular and infection microbiology, 2017, Vol.7, pp.246PubMed
摘要:Objectives: The emergence of carbapenem-resistant Enterobacteriaceae , especially Klebsiella pneumoniae , has become a major concern in clinic settings. Combination therapy is gaining momentum to counter the secondary resistance and potential suboptimal efficacy of monothera...
作者:Niu Tianshui , Luo Qixia ...
来源:[J].Antimicrobial resistance and infection control, 2019, Vol.8, pp.52PubMed
摘要:Background(#br)We retrospectively analyzed the effect of tigecycline and cefoperazone/sulbactam therapies on the prognosis of patients with carbapenem-resistant Acinetobacter baumannii bloodstream infection (CRAB-BSI).(#br)Methods(#br)CRAB-BSI patients receiving tigecycline thera...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×